Fluvoxamine, melatonin and COVID-19

被引：0

作者：

George M. Anderson

机构：

[1] Yale University School of Medicine,Child Study Center and the Department of Laboratory Medicine

来源：

Psychopharmacology | 2021年 / 238卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：611 / 611

共 50 条

[21] Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 Reply
Bramante, Carolyn T.
Buse, John B.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24) : E65 - E65
[22] Melatonin, Oxidative Stress and COVID-19
Reiter, Russel
FREE RADICAL BIOLOGY AND MEDICINE, 2020, 159 : S3 - S3
[23] Delirium, sleep, COVID-19 and melatonin
Wiwanitkit, Viroj
SLEEP MEDICINE, 2020, 75 : 542 - 542
[24] Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
Seo, Hyeonji
Chong, Yong Pil
INFECTION AND CHEMOTHERAPY, 2022, 54 (02) : 370 - 371
[25] Therapeutic potential of fluvoxamine in COVID-19 outpatients: a case report
Rudez, Lorena Karla
Sklebar, Tin
Calusic, Martina
Jurkovic, Ivan
Kirsch, Steven
Likic, Robert
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (12) : 4880 - 4881
[26] Fluvoxamine for non-hospitalized patients affected with COVID-19
Wu, Peter E.
Austin, Emily
Leong, Derek
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (11) : E437 - E438
[27] Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19
Mahdi, Mohamed
Herman, Levente
Rethelyi, Janos M.
Balint, Balint Laszlo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
[28] Fluvoxamine for outpatients with COVID-19: where do we stand?
Berwanger, Otavio
LANCET GLOBAL HEALTH, 2022, 10 (01): : E2 - E3
[29] COVID-19: Melatonin as a potential adjuvant treatment
Salles, Cristina
LIFE SCIENCES, 2020, 253
[30] RETROSPECTIVE REVIEW OF MELATONIN IN PATIENTS WITH COVID-19
Sahu, Nitasa
Ramzy, Joseph
Corwin, Douglas
Rahman, Awan
Stoltzfus, Jill
Guglielmello, Giuseppe
CHEST, 2021, 160 (04) : 560A - 560A

← 1 2 3 4 5 →